NeoVentures Biotechnology develops custom aptamer for diagnostic and therapeutic applications. NeoVentures is the global leader in aptamer discovery. We help you develop aptamers that lead to new market opportunities for which you have full commercial rights. Our company, NeoVentures Biotechnology was the first globally tocommercialize an aptamer based diagnostic device with our series of products for mycotoxin detection back in 2008.We have developed aptamer based detection systems with LODs in the fM range in flow through devices. We have created novel assays for molecules too small for antibody detection. We have demonstrated the capacity of aptamers for the detection of human cells and for the identification of infective organisms.Lets put you ahead of your competitors To get a free consultation visitneoaptamers.com/free-consultation CONTACT USneoaptamers.comNeoVentures Biotechnology Inc.1-519-601-7511info@neoventures.ca